Column

Internal business intelligence is essential for healthcare decision making.

Healthcare providers should keep certain best practices in mind when choosing new technology in 2019.

HFMA President and CEO Joe Fifer discusses implications of a new federal report that addresses price transparency.

Cross-professional partnerships can enhance healthcare organizations ability to achieve shared goals of improving the patient experience, reducing the cost of care, and improving population health.

A payment change in the OPPS final rule that aims to align payments made for services delivered in off-campus hospital outpatient departments with those made for services delivered in physician offices has raised considerable controversy.

Disruption from new market entrants and issues around price transparency are among the trends that could make life difficult for traditional healthcare stakeholders if they fail to adapt.

Crowdfunding can increase investor participation and engagement between project initiators and potential funders, as well as raise awareness of neglected health issues.

As they modify their strategies to account for change in 2019, healthcare organizations should consider how risks and rewards might have changed and where they might best redeploy their dollars.

The healthcare sectors’ extended access to abundant, low-cost, and relatively low-risk capital will change in 2019, and tracking four key issues will illuminate how those changes impact capital finance.

HFMA President and CEO Joe Fifer discusses why today’s healthcare challenges transcend politics—and the implications for healthcare finance leaders.